Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market
You're going to hear a lot about Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market.
It'll be co-promoted by Searle and Pfizer.
Celebrex is approved for osteo- and rheumatoid arthritis. It's as effective as other NSAIDs for joint pain and swelling.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote